Abstract
The prognosis for hepatobiliary malignancies is dismal. Surgery remains the primary curative option. The positron emission tomography/computed tomography (PET/CT) provides simultaneous metabolic and anatomic information on tumors in the same imaging session. The role of PET/CT in detecting hepatobiliary malignancies has not yet been established. The purpose of this review was to examine the literature on the use of PET/CT in cholangiocarcinomas, also in order to improve the preoperative staging and the restaging, for a proper oncology management of patients.
MeSH terms
-
Artifacts
-
Bile Duct Neoplasms / diagnostic imaging*
-
Bile Duct Neoplasms / pathology
-
Bile Duct Neoplasms / radiotherapy
-
Bile Duct Neoplasms / surgery
-
Bile Ducts, Intrahepatic / diagnostic imaging*
-
Bile Ducts, Intrahepatic / pathology
-
Cholangiocarcinoma / diagnostic imaging*
-
Cholangiocarcinoma / pathology
-
Cholangiocarcinoma / radiotherapy
-
Cholangiocarcinoma / surgery
-
Combined Modality Therapy
-
Diagnostic Errors
-
Embolization, Therapeutic / methods
-
Fluorine Radioisotopes*
-
Fluorodeoxyglucose F18*
-
Hepatectomy
-
Humans
-
Multimodal Imaging / methods*
-
Neoplasm Staging / methods*
-
Radionuclide Imaging
-
Radiopharmaceuticals* / therapeutic use
-
Treatment Outcome
-
Whole Body Imaging / methods
-
Yttrium Radioisotopes / therapeutic use
Substances
-
Fluorine Radioisotopes
-
Radiopharmaceuticals
-
Yttrium Radioisotopes
-
Fluorodeoxyglucose F18